View Cart  

FDA Warns Indiana Hospital IRB for Inadequate Pediatric Protections

A A
The FDA has handed a warning letter to the Memorial Hospital of South Bend institutional review board (IRB) for failing to adequately protect child participants in clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily